There is a growing interest in understanding the fate and behaviour of probiotic microorganisms and bioactive compounds during passage of the human gastrointestinal tract (GIT). Here, we report the development of a small volume in vitro model called The smallest Intestine (TSI) with increased throughput focusing on simulating passage through the stomach and small intestine (SI). The basic TSI module consists of five reactors, with a working volume of 12 ml each. During the simulated passage through the SI, bile is absorbed and pH is adjusted to physiologically relevant values for duodenum, jejunum and ileum. A consortium of seven representative bacterial members of the ileum microbiota is included in the ileal stage of the model. The behaviour of three putative probiotic Lactobacillus strains during in vitro simulated upper GIT passage was tested in the model and results were compared to previous studies describing probiotic survival. It was found, that probiotic persistence is strongly related to whether food was ingested, but also to presence of the ileal microbiota, which significantly impacted probiotic survival. In conclusion, TSI allows testing a substantial number of samples, at low cost and short time, and is thus suitable as an in vitro screening platform.
INTRODUCTION
There is a strong interest in finding efficient ways to investigate the behaviour of drugs, food additives, bioactives and probiotics in the GIT. Probiotics are live microorganisms that when ingested in appropriate amounts have beneficial effects on host health (Hill et al. 2014) . Recent findings suggest that certain strains have a positive impact on e.g. lactose intolerance, enteritis, gastritis and antibiotic-induced diarrhoea (Iannitti and Palmieri 2010; Pakdaman et al. 2016; Szajewska et al. 2016) . Abbreviations: SHIME, Simulator of the Human intestinal microbial ecosystem; TIM -1, TNO gastro-intestinal tract model; ESIN, Engineered stomach and small intestine; IViDiS, In Vitro Digestive System.
The small intestine (SI) is consisting of three distinct sections: duodenum, jejunum and ileum (Schneeman 2002) . The duodenum is the shortest part of the SI where bile salts and enzymes from the pancreas are secreted to breakdown and solubilize fats, proteins and carbohydrates. The duodenal concentration of bile varies from around 4 mM (fasted state) to 10 mM (fed conditions) (Kalantzi et al. 2006a ; El-Aidy, van den Bogert and Kleerebezem 2015; Riethorst et al. 2016) . The jejunum and ileum are mainly responsible for the absorption of small nutrients (carbohydrates, amino acids and fatty acids), minerals and active reabsorption of bile salts. The bacterial density increases throughout the SI ranging from 10 3 cells g −1 in duodenum to a more dense population of 106-108 cells g −1 in the ileum (Zoetendal, Rajilic-Stojanovic and de Vos 2008) . At present, our knowledge of the composition of the SI microbiota is rather scarce, but recent studies indicate that in healthy subjects Streptococcus, Veillonella, Haemophilus, Escherichia spp. among others are commonly found commensals (Chung et al. 2015; Dlugosz et al. 2015) . Intervention studies both on animals and humans remain the golden standard for testing the effect of probiotics, but they are also tedious and mechanistic studies are virtually impossible. Despite the advantages of having a live organism that can mimic all physiological aspects of the GIT, in vivo models have several disadvantages. Animals are still physiology different from humans, above that according to the 3R framework (Replacement, Reduction and Refinement), the usage of animals in experimental studies should be reduced and, if possible replaced, to limit the number of experimental animals used. To tackle these challenges, a variety of in vitro models of the upper as well as the lower GIT have been developed. These models chiefly fall in two groups according to sample movement, namely static models and dynamic models (Guerra et al. 2012) .
Static models are based on a single reactor where the pH is usually fixed during the simulation (pH 1-3 for stomach and pH 6-7 in the SI phase). Those models lack dynamic changes of pH along the process, gastric emptying and absorption simulation. Static models are useful for screening large number of samples, but they are also very much simplified. Many different protocols are also in use, making comparison of results between research groups challenging. To tackle this problem an INFOGEST working group recently published a standardised static in vitro digestion protocol (Minekus et al. 2014) , which is now widely used.
The most complex in vitro models reproduce processes occurring in the SI such as: bile salts and small nutrient absorption, dynamic changes of pH, reproduction and simulation of enzymes secretion rates and realistic transit times (Table 1) . All existing models operate with relatively large volumes, and thus require large amounts of sample material for testing and thus high experimental costs. A relatively low throughput (up to two replicates per experiment) is a further challenge. None of the existing models mimic the SI microbiota, even though recent findings indicate that especially the ileal microbiota plays an important role in the metabolism of nutrients and influences absorption of bioactives (El-Aidy, van den Bogert and Kleerebezem 2015), as well as in short oligosaccharide and plant cell wall polysaccharide degradation, carbohydrate uptake and energy metabolism (Zoetendal et al. 2012) . Therefore, the addition of a SI microbiota to an in vitro SI model might offer a valuable tool for studying the interplay between probiotics, prebiotics, SI microbiota and bioavailability of bioactives.
The aim of the present study was to develop a small volume in vitro model of the human SI (duodenum, jejunum and ileum) with increased throughput as a screening platform for studying microbial behaviour such as survival of probiotics, and digestion of certain food components during SI passage.
MATERIALS AND METHODS

Microorganisms and growth conditions
Seven bacterial strains representing prominent members of the ileal microbiota were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ) ( Table 2 ). All strains were cultured anaerobically at 37
• C in Gifu Anaerobic Medium (GAM Broth, NISSUI) and stored at −80 • C until use.
Three strains with putative probiotic properties were also included (Table 2) . Lactobacillus rhamnosus GG (DSM 20 021) was purchased from DSMZ, L. plantarum (LP80 pCBH1 GZH +) encoding a bile salts hydrolase enzyme (EC 3.5.1.24) was obtained from Ghent University, Belgium. Lactobacillus casei Z11 isolated from an adult human intestinal biopsy (Larsen et al. 2009 ) was obtained from the culture collection at Department of Food Science, University of Copenhagen, Denmark. All three strains were cultured anaerobically at 37
• C in deMan, Rogosa and Sharpe broth (MRS, Oxoid) for 24 h and stored at −80 • C until use.
Prior to the experiments each strain from the SI microbiota was inoculated in 10 ml GAM broth and cultured in 37
• C for the time appropriate for each strain (Table 2) . After this, tubes were centrifuged (5000 g for 2 min), the supernatant was discarded and the pellet was re-suspended in the volume of phosphate buffered saline (pH 7.4) appropriate to obtain a suspension of 10 8 CFU ml −1 according to growth curves developed for each strain (OD vs. CFU ml −1 ). All strains were mixed together before addition to the reactor at the ileum stage of the simulation. 
The Smallest Intestine in vitro model
The Smallest Intestine in vitro model (TSI) simulates the passage through the human SI by an adjustment of pH and concentration of bile salts, pancreatic enzymes and dialysis to mimic absorption. Each TSI unit consist of five batch-like reactors, each of them simulates the SI of one individual enabling the test of five samples of the same time. The reactors have a working volume of 12 ml. Fig. 1 depicts the experimental flow, simulating passage of duodenum, jejunum and ileum. Parts of the model (outer cabinet, temperature and pH control) are adapted from the design of the recently developed CoMiniGut in vitro colon model (Wiese et al. 2018) .
The main unit of TSI is a composite climate box ( Fig. 2 ) where temperature is controlled (37
• C) by flow of water from a circulating water bath (A10/AC150, ThermoScentific) through a copper/aluminium heat exchanger placed inside of the box. An external temperature sensor connected with the water bath and placed inside of the main unit constantly monitors the temperature. During the whole experiment temperature is recorded by an independent temperature data logger (Temp 101A, MadgeTech). Each box contains five-stirred fused quartz glass reactors (AdValue Technology, USA), where each one represents the passage through the SI of one individual (Fig. 2) . Reactors are separately closed in PVC chambers and can be constantly flushed with nitrogen to provide anaerobic conditions. Alternatively, anaerobic conditions can be achieved by using anaerobic sachets (Oxoid AnaeroGen, ThermoScientific). Anaerobic conditions are verified by Oxoid Anaerobic Indicators (BR0055, Oxoid).
Chambers are placed on a five-unit magnetic stirrer plate (R05, IKA), which assures equal mixing of samples inside of the reactors. The reactors are closed with a septa lid (GR-2 rubber, Sigma-Aldrich) containing a pH probe inlet and needle inlets for the supply of enzymes and bile salts, as well as sampling, input and output for the dialysis chamber. Bile is absorbed during a dialysis process using dialysis cassettes (Slide-A-Lyser G2, ThermoScientific). The cassettes are placed in a chamber made of PVC with a septa lid that ensures anaerobic conditions inside. The dialysis chamber is filled with dialysis fluid. A multichannel peristaltic pump (205S, Watson-Marlow) ensures constant flow of the chyme between the reactor and the dialysis cassettes. Beakers are stirred continuously (170 rpm) to facilitate effective dialysis. The dialysis has a cut-off of 10 kDa small nutrients and electrolytes from the chyme smaller than this are thus also absorbed. The pH in each module is measured every 20 sec using SP28X pH electrodes (Consort). The readout is sent to the computer that according to the pre-set value decides on the dosing. The pH of each reactor is controlled with 0.1 M NaOH according to the pre-programmed experimental setup using syringe pumps (NE-500, WPI) automatically controlled using in-house made scripts in the Matlab software (ver. R2015a, TheMathWorks). Regulating pH with base solution only is sufficient due to constant acidification of the reactor contents.
To simulate the electrolyte composition and osmotic pressure occurring in the human GIT-simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) were used (Minekus et al. 2014) . The SIF composition was modified by removal of sodium bicarbonate to allow more precise pH control during experiments. All of the TSI reactors were prepared by adding 4.1 ml of SGF, 3 ml or 4.5 ml of SIF depending if the experiment was conducted as simulating fed or fasted state, and 10 μl of 0.6 M CaCl 2 . To simulate the duodenum, pancreatic juice, bile solution and feed/water were added. Pancreatic juice was added as a mixture (100 mg ml −1 ) of SIF and 8x USP (United States Pharmacopedia unit) pancreatine from porcine pancreas (Sigma-Aldrich). This provides an enzyme composition close to what is found in humans (Minekus et al. 2014) . The amount of pancreatic juice added was established according to the activity of trypsin which was at a level of 100 U ml −1 in fed conditions (Saif et al. 1996; Minekus et al. 2014) and 40 U ml −1 in fasted state.
A stock solution of 80 g l −1 bile salts (Bile extract porcine, Sigma-Aldrich) in SIF was prepared in anoxic conditions and the exact concentration of bile salts was determined using a commercially available kit (TBA Assay, Diazyme). To simulate conditions after ingestion of a meal, 'fed state' was mimicked by the presence of 10 mM bile salts in the reactor and with addition of 1.4 ml of food replacement (Nutrison Energy, Nutricia) as a source of nutrients. SI passage without the presence of food components was simulated by a 'fasted state' by presence of 4 mM bile acids and 1.4 ml of water. Before each run, pH was adjusted (by syringe) to 6.5 by titrating with 1 M NaOH. During the duodenal passage (2 h) pH was elevated from 6.5 to 6.8 in steady increments (Fig. S1, Supporting  Information) . Next, the absorption of small nutrients and bile salts in the jejunum was simulated by continuously pumping the samples through the dialysis chambers with a 10 kDa membrane cut-off at a pumping rate of 2.64 ml min −1 for 4 h, as specified above. During the 4-h simulation of the jejunal passage pH was increased from 6.8 to 7.2. To simulate ileum, fresh SIF with a pH of 7.2 was added to the reactor to obtain a chyme to SIF ratio of 50:40 (v/v). Moreover 1 ml of SI microbiota inoculum (Table 2) was added. The inoculum was adjusted to obtain 10 7 CFU ml −1 in the reactor. During simulated ileal stage (2 h) pH was kept constant at 7.2 and the amount of base used to control pH was constantly recorded. After 8 h of SI stage samples were taken to check the concentration of bile salts (TBA Assay, Diazyme). Due to full flexibility of the model, all parameters, including duration time of each stage can be adjusted according to experimental setup. To test bacterial resistance to bile salts, we decided to set 2-h incubation time in duodenum.
Survival of probiotic strains during simulated small intestinal passage
As a proof of concept survival of three probiotic strains was tested in TSI model to demonstrate its feasibility for simulation of SI conditions. Each probiotic strain (Table 2 ) was inoculated in 10 ml MRS broth medium and cultured for 24 h. Cells were harvested by centrifugation (10 000 g for 2 min) after which the supernatant was discarded and the pellets resuspended in 10 ml of phosphate buffered saline (pH 7.4). Four reactors were inoculated with 0.5 ml of bacterial solution, while the fifth was kept as a control to check for contamination in any of the compartments used along the experiment. Survival was evaluated after 8 h of simulated digestion via colony plate counts on MRS agar medium (37 • C, 24 h, anaerobic incubation) after serial dilution using a saline solution (0.9% NaCl in water). Experiments were conducted separately for each probiotic strain and two different feeding conditions in triplicates. Moreover, the influence of ileal microbiota presence on survival of probiotic strains in the SI was investigated by comparison of probiotic survival with and without the presence of a SI microbial consortium.
Simplified stomach protocol for simulation of gastric conditions
Even though primarily developed to simulate the SI, the TSI model can be adjusted to simulate human stomach conditions in fed and fasted state if desired. SGF and SSF fluids were prepared as described by Minekus (Minekus et al. 2014) . To mimic stomach conditions, TSI reactors were prepared by mixing 0.5 ml of probiotic culture with 0.9 ml of food replacement (fed conditions, Nutrison Energy, Nutricia) or water (fasted conditions), and 1.4 ml of SSF (pH 7). Then, a mixture of 2.3 ml of SGF (pH 3) and 0.5 ml of pepsin solution was added into the reactor in order to reach 2000 U ml −1 of pepsin in the final volume (Schneeman 2002; Minekus et al. 2014) . The pH throughout the experiment was stabilized according to average pH in human stomach measured in vivo on human volunteers. (Dressman et al. 1990; Tyssandier et al. 2003; Kalantzi et al. 2006b ). By using 0.5 M HCl the pH was adjusted and kept during the whole simulation pH 2 (in fasted stage) or pH 4 (in fed stage). Simulation took 2 h in fed state, which is half the emptying time of semi-solid foods, and 1 h in fasted conditions, which is the time for water to transit through the stomach (Lin et al. 2005; Goetze et al. 2007 ). Subsequently, 1 M NaOH was titrated to reach pH 6 in order to stop activity of pepsin. Survival was measured via plating on MRS agar medium as stated above. Each experiment was performed in triplicates (n = 3).
Statistical analysis
All statistical analyses were performed using the Prism 7 v 7.0b software (GraphPad). Differences between groups were calculated using paired/unpaired t-test, and one-way ANOVA with Tukey's multiple comparisons test, with a single pooled variance. Significance was determined at the P < 0.05 levels.
RESULTS
Basic parameters during a TSI run
During all the experiments, pH was measured and controlled. The pH profile during simulated SI passage was based on the results obtained from sampling with the IntelliCap R system (Koziolek et al. 2015) . The pH profile during the entire simulated SI passage (8 h) was with an average standard deviation of ± 0.02 between all 36 runs (Fig. S1, Supporting Information) . Along the entire experiment sodium hydroxide was pumped to control the pH in each of the reactors. The amount of alkali used to maintain pH during the experiment, according to probiotic strains and feeding conditions, was monitored. There was no relationship between volume of sodium hydroxide used and probiotic strain tested (data not shown). On the other hand, base consumption correlated with feeding conditions. On average during fed state 717.44 ± 35.00 μl of base was used versus 564.44 ± 22.90 μl in fasted state (P = 0.05). The bile salts concentration was measured at the beginning and at the end of the experiment in each of the reactors. On average the initial amount of bile salts was lowered by 61.98 ± 1.58% (n = 36; data not shown). There was no significant influence of feeding conditions and probiotic bacteria presence on bile salts absorption (P = 0.34).
Survival of probiotic bacteria in simplified gastric compartment
Gastric conditions can be simulated in TSI model in both 'fasted' (i.e. after ingestion of a glass of water) and 'fed' state (after ingestion of food). Persistence of the three putatively probiotic strains was tested during passage of the simplified gastric conditions (Table 3 ). In fed conditions (pH 4, t = 120 min) all strains showed good survival, without any significant changes in number of live cells. To elucidate dynamics of probiotic survival in fasted conditions (pH 2, t = 60 min), samples were taken every 20 min for 1 h. Lactobacillus plantarum LP80 was the most susceptible bacterium 
L. casei Z11 (log CFU g towards fasted gastric conditions. The number of cultivable cells went below detection limit already after 20 min. Survival of L. casei Z11 was good during the first 20 min of experiment where the number of cultivable cells did not change significantly (Table 3 , P = 0.07). At the second sampling point after 40 min, the number of cultivable cells went below detection limit. The number of cultivable L. rhamnosus GG cells went down with time more gradually (Table 3) .
Probiotic bacteria survival during simulated small intestine passage
The survival of the three probiotic strains was tested in TSI model in two different feeding conditions: conditions mimicking a 'fasted' SI (bile salts = 4 mM; pancreatic juice = 40 U ml −1 ) and a 'fed' SI (bile salts = 10 mM; pancreatic juice = 100 U ml −1 ). The influence of the SI microbiota consortium was tested in both feeding states (Fig. 3) . Lactobacillus plantarum LP80, which is bile salt hydrolase positive, showed good survival in both feeding conditions without the presence of the SI microbiota ( Fig. 3 ; Fasted: P = 0.38, Fed: P = 0.18). Interestingly, the addition of an ileal microbiota resulted in a significantly decreased survival of L. plantarum LP80 in both feeding states ( Fig. 3 ; Fasted: P = 0.02, Fed: P = 0.03). L. rhamnosus GG survived well in the fasted state without ileal microbiota and moderately in fasted conditions with ileal microbiota. It showed poor survival when facing high concentrations of bile salts in the 'fed' state ( Fig. 3 ; P < 0.001 all experiments). Among the three tested strains, L. casei Z11 was most susceptible to bile acids. It showed moderate survival in fasted conditions without ileal microbiota, but during fed conditions and when including the ileal microbiota survival was significantly reduced ( Fig. 3 . P < 0.001 in all the experiments).
DISCUSSION
Development of the TSI in vitro model
Our low volume and increased throughput in vitro model of the human SI consists of 5 units, each representing one individual, which can be multiplied with additional modules if large numbers of samples need to be tested in parallel. All parameters of the model were set based on in vitro data from various human SI samplings and in vitro digestion protocols. Values for pH in each of the three stages were based on values from human volunteers (Dressman et al. 1990; Fallingborg et al. 1990; Fallingborg, Pedersen and Jacobsen 1998; Koziolek et al. 2015) . Concentrations of bile salts and pancreatic juice were chosen based on in vivo data (Gullo et al. 1988; Kalantzi et al. 2006b; McConnell, Fadda and Basit 2008) , complemented with values used in other static and dynamic in vitro models (Molly, Woestyne and Verstraete 1993; Minekus, Marteau and Havenaar 1995; Minekus et al. 2014) . The incorporation of a dialysis module allows simulation of bile absorption of bile salts and smaller nutrients, though with the limitation, that in the TSI model molecule size is the main factor influencing absorption, whereas in vivo the SI epithelium is more permeable to some molecules than others due to the presence of specific transporters (Suzuki and Sugiyama 2000; Cragg et al. 2005) .
Thanks to the usage of inexpensive materials and commercially available devices, the TSI model provides a cost-effective alternative to large and custom-made GIT models available on the market. Moreover, the small working volume allows to study more samples at the time, which decreases significantly the cost per tested sample and allows to decrease statistical interferences. Lactobacillus rhamnosus GG and (C) Lactobacillus casei Z11. Significant differences in survival of bacteria before and after each experiment were marked. Moreover, significant impact of ileal microbiota on probiotic survival was marked above bars for each experiment. All experiments were performed in triplicates (n = 3).
Ileum microbial consortium
A conglomerate of seven strains were created in order to produce a simple, but representative microbiota of the SI (Thadepalli et al. 1979; Wang et al. 2003; Hayashi et al. 2005; Wang, Ahrné and Jeppsson 2005; Booijink et al. 2010; van den Bogert et al. 2013) . This is a unique characteristic of TSI, being the first in vitro model to incorporate or mimic SI microbiota. The chosen strains were all of human origin and had to be resistant towards bile acids as the bile acid concentration at the beginning of the ileal stage is still relatively high. An advantage of the defined consortium based on culture collection strains, compared to e.g. a faecal inoculum, is that while faecal inoculum sooner or later will be exhausted, the defined inoculum can always be reconstituted. Moreover, faecal samples are not necessarily a good representation of SI microbiota (Chung et al. 2015) . The SI is the place where food components during digestion encounter microbes in higher numbers for the first time after ingestion. It also characterised by high transit speed (Yu and Amidon 1998) . Therefore, the ileum microbiota is specialised in fast uptake and conversion of relatively simple carbohydrates, in contrast to the colonic microbiota which is efficient in the degradation of complex carbohydrates (Zoetendal et al. 2012) .
Probiotic bacteria survival in TSI model
Probiotics as a dietary supplement are administrated orally. Thus, to exert their positive effect on the host they have to survive the passage through the harsh environment of the upper GIT, with the main limiting factor being the low pH in the stomach (Morelli 2000; Kailasapathy 2006) . In experiments simulating the stomach in fed state with elevated pH and presence of nutrients all three strains survive perfectly. These results are in line with previous studies showing that addition of nutrients significantly improves survival of L. rhamnosus GG (Corcoran et al. 2005) . In the fasted state, the tested bacteria showed diverse survival, but none of them manages to thrive 60 min at pH 2. These results are comparable to previously published studies, where number of cultivable cells goes below detection level within the first 40 min of the incubation (Corcoran et al. 2005; Doherty et al. 2012) .
Detailed studies on probiotics survival in the human SI are scarce due to difficulties with material sampling and ethical constrains. To address this issue, the TSI in vitro model was developed and applied to determine probiotic survival by simulating conditions resembling various sections of the human SI (duodenum, jejunum and ileum), in both 'fed' and 'fasted' conditions, with and without the presence of simulated ileal microbiota. The three tested probiotics strains exhibit diverse resistance towards SI conditions. Lactobacillus plantarum LP80 survived well, even at a high concentration of bile salts (Fig. 3) . This was expected as this strain produces bile salt hydrolase enzyme (Begley, Gahan and Hill 2005; Begley, Hill and Gahan 2006; Ridlon et al. 2014) , and due to this ability we used this strain as a positive control in our experiments. In regards to L. casei Z11 results from the TSI model show poor survival of this probiotic (3.5 log reduction on average). This is possibly due to a long incubation time in the presence of bile salts, and pancreatic juice containing protease enzymes or a mixture of both. Lactobacillus casei Shirota has previously been found to show good survival in the SI, indicating that different strains of L. casei show divergent resistance towards the harsh conditions in the gut (Oozeer et al. 2006; Wang et al. 2015) .
To date no other in vitro setup includes a simulated SI microbiota. Usage of the mix of seven strains instead of for example inoculation with stoma effluent was a way to standardize the model. Here. we show, that probiotic survival during simulated SI passages indeed was influenced by the presence of the ileal microbiota. In five out of six experiments we observed a significant difference in probiotic survival between experiments performed with and without the inoculum. This effect is more pronounced in 'fasted' reactors, due to lower concentration of bile salts and higher probiotic survival rate.
The in vitro model of the SI presented in this study has a potential to become a screening platform for modelling microbial survival during the passage of the human SI. Thanks to affordable and exchangeable reactors and peripheries the TSI model can be applied for testing pathogenic and spore forming bacteria. The versatility of the model allows to change all the parameters depending on research question and adjust it to simulate apart from human, also other monogastric animals such as pigs, dogs etc.
Summarizing, the TSI is a novel SI in vitro model that will be particularly useful for screening purposes, where it is desirable to work with relatively small volumes and/or when the SI microbiota needs to be taken into the equation, and/or when assessing SI passage of microbes or enzymes. The TSI simulates closely relevant parameters of human GIT such as pH, transit time, enzymes and bile salts concentration.
